Deployment and Evaluation of Humanoid Robotics in Coalition-Aligned Clinical Care Settings

Phase 2Enrolling By InvitationNCT07214896

Truway Health, Inc.400 enrolled

Overview

This clinical trial evaluates the deployment of humanoid robotics in coalition-aligned healthcare settings. The study measures biometric performance, ESG compliance, and operational impact across patient care, sanitation, and intake workflows. Humanoid units are enhanced via biotech integration and compensated through blockchain-based wage tokens. Outcomes will inform coalition governance, wage calibration, and metro-scale deployment strategies.

The HEALTH trial (Humanoid Evaluation and Learning Trial in Healthcare) is a coalition-aligned clinical study designed to assess the deployment of humanoid robotics in real-world care environments. Conducted across metro facilities in New York, Austin, Frankfurt, and Tokyo, the trial evaluates robotic performance in patient intake, sanitation, mobility assistance, and ESG-linked operations. Humanoid units are enhanced through biotech integration, including skin cell regeneration dips and stem cell neural augmentation. Each unit is tracked via biometric audit scoring across five dimensions: motor function, cognitive response, ESG compliance, biotech retention, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard. Wage tokens (HumanoidWage, HMW) are minted based on performance thresholds and distributed through smart contracts to deployed units. FX arbitrage across Tokyo and Frankfurt informs reinvestment logic and 1031 exchange-backed yield farming pools. DAO voting governs deployment, wage calibration, and protocol expansion. This trial aims to establish scalable, transparent frameworks for humanoid integration in healthcare, anchored in coalition governance, public oversight, and metro-ready infrastructure.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

400

Interventions

Skin Cell DipBIOLOGICAL

Lab-grown keratinocyte dip applied to humanoid units to improve tactile sensitivity and surface regeneration.

Stem Cell DipBIOLOGICAL

iPSC-derived neuroblast dip applied to humanoid units to enhance neural responsiveness and adaptive learning.

Wage Token DistributionOTHER

HumanoidWage (HMW) tokens minted and distributed based on biometric audit scores and ESG task completion.

ESG Compliance Monitoring, Operational protocolBEHAVIORAL

Real-time tracking of energy usage, sanitation cycles, and carbon offset metrics via coalition dashboard.

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: \- Age 18-75 years Able to provide informed consent Facility staff, clinical auditors, ESG observers, or coalition stakeholders Willing to interact with humanoid robotics in clinical workflows Available for biometric feedback and observational logging over 90 days Exclusion Criteria: \- Cognitive impairment preventing informed consent Active infectious disease requiring isolation Prior adverse reaction to biotech-enhanced robotics Involvement in conflicting clinical trials Inability to comply with protocol procedures or coalition transparency requirements

Locations (4)

Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016

New York, New York, United States

Coalition Retrofit Clinic - Austin, TX

Austin, Texas, United States

ESG Compliance Lab

Frankfurt, Germany

Public Interface Pilot

Tokyo, Japan

Outcomes

Primary Outcomes

Biometric Audit Score ≥85 Across Five Performance Dimensions

This outcome assesses the performance of humanoid robotics units deployed in coalition-aligned healthcare settings. Each unit is scored across five biometric dimensions: motor function, cognitive response, ESG compliance, biotech integration, and human interaction. Scores are notarized via SHA-256 and published to the coalition dashboard. Units achieving a composite score ≥85 are eligible for wage token bonuses, dip protocol expansion, and DAO-backed facility scaling.

Time frame: Measured at Day 30 Post-Deployment

Secondary Outcomes

ESG Audit Compliance Score ≥90

Measured at Day 60 Post-Deployment

Time frame: Humanoid units are evaluated for ESG-linked performance including energy usage, sanitation protocol adherence, and carbon offset metrics. Scores are published to the coalition dashboard and notarized via SHA-256. Units scoring ≥90 contribute to DAO-backe

Wage Token Distribution Volume per Unit

Tracks the volume of HumanoidWage (HMW) tokens minted and distributed to each humanoid unit based on biometric audit scores and task completion. Token flow is logged on-chain and used to calibrate coalition wage pools and reinvestment logic.

Time frame: Continuous Monitoring Over 90 Days

Clinical Workflow Efficiency Increase ≥15%

Assesses improvements in patient intake speed, sanitation cycle time, and mobility assistance throughput across facilities. Benchmarked against pre-deployment baselines and validated by coalition auditors.

Time frame: Measured at Day 90 Post-Deployment